US 11,866,750 B2
Endolysin variant
Martin Griessl, Hohenschambach (DE)
Assigned to SASINAPAS CO., LTD., Bangkok (TH)
Filed by SASINAPAS CO., LTD., Bangkok (TH)
Filed on Nov. 18, 2021, as Appl. No. 17/530,142.
Application 17/530,142 is a division of application No. 16/304,355, granted, now 11,208,646, previously published as PCT/IB2017/053099, filed on May 26, 2017.
Claims priority of application No. PCT/TH2016/000048 (WO), filed on May 27, 2016.
Prior Publication US 2022/0064623 A1, Mar. 3, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 9/80 (2006.01); A61P 31/04 (2006.01)
CPC C12N 9/80 (2013.01) [A61P 31/04 (2018.01)] 14 Claims
 
1. A nucleic acid encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:1, wherein SEQ ID NO:1 is characterized by:
X5 may be any amino acid,
X13 may be any amino acid,
X72 may be L or S,
X98 may be any amino acid;
with the proviso that the polypeptide does neither comprise the sequence according to SEQ ID NO:2, nor the sequence according to SEQ ID NO:3, nor the sequence according to SEQ ID NO:4.